936901-74-5 Usage
Description
(1s,3s)-3-(8-Bromo-1-chloroH-pyrrolo[1,2-a]pyrazin-6-yl)-1-methylcyclobutanol is a complex organic molecule that features a cyclobutanol ring with a methyl group and a bromine-chlorine substituted pyrrolopyrazine group. This unique structure endows it with potential interactions with biological targets, making it a promising candidate for medicinal chemistry and drug discovery.
Uses
Used in Medicinal Chemistry:
(1s,3s)-3-(8-Bromo-1-chloroH-pyrrolo[1,2-a]pyrazin-6-yl)-1-methylcyclobutanol is used as a compound in medicinal chemistry for its potential to interact with biological targets, which could lead to the development of new drugs and therapies.
Used in Drug Discovery:
In the field of drug discovery, (1s,3s)-3-(8-Bromo-1-chloroH-pyrrolo[1,2-a]pyrazin-6-yl)-1-methylcyclobutanol is utilized for its unique structure and potential pharmacological properties, which may contribute to the identification of novel therapeutic agents.
Used in Scientific Research:
(1s,3s)-3-(8-Bromo-1-chloroH-pyrrolo[1,2-a]pyrazin-6-yl)-1-methylcyclobutanol serves as a valuable tool in scientific research, where its synthesis and characterization can provide insights into the development of new organic compounds and their applications.
Used in Organic Chemistry:
In the realm of organic chemistry, (1s,3s)-3-(8-Bromo-1-chloroH-pyrrolo[1,2-a]pyrazin-6-yl)-1-methylcyclobutanol is of interest to chemists and researchers for its synthesis and potential as a building block for the creation of new complex organic molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 936901-74-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,6,9,0 and 1 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 936901-74:
(8*9)+(7*3)+(6*6)+(5*9)+(4*0)+(3*1)+(2*7)+(1*4)=195
195 % 10 = 5
So 936901-74-5 is a valid CAS Registry Number.
936901-74-5Relevant articles and documents
Discovery of potent, selective and orally bioavailable imidazo[1,5-a] pyrazine derived ACK1 inhibitors
Jin, Meizhong,Wang, Jing,Kleinberg, Andrew,Kadalbajoo, Mridula,Siu, Kam W.,Cooke, Andrew,Bittner, Mark A.,Yao, Yan,Thelemann, April,Ji, Qunsheng,Bhagwat, Shripad,Mulvihill, Kristen M.,Rechka, Josef A.,Pachter, Jonathan A.,Crew, Andrew P.,Epstein, David,Mulvihill, Mark J.
, p. 979 - 984 (2013/03/13)
This Letter describes the medicinal chemistry effort towards a series of novel imidazo[1,5-a]pyrazine derived inhibitors of ACK1. Virtual screening led to the discovery of the initial hit, and subsequent exploration of structure-activity relationships and
Fused bicyclic mTOR inhibitors
-
Page/Page column 62, (2008/06/13)
Compounds represented by Formula (I) or a pharmaceutically acceptable salt thereof, are inhibitors of mTOR and useful in the treatment of cancer.
